Ann Howell

Ann Howell is currently serving as Vice President of Regulatory Affairs at OnKure Therapeutics since September 2023. Prior to this role, Ann held the position of Vice President and Head of Forma Regulatory Affairs at Novo Nordisk from October 2022 to September 2023, as well as Vice President and Executive Director of Regulatory Affairs at Forma Therapeutics from May 2020 to May 2023. Ann's experience also includes serving as Senior Director of Regulatory Affairs at Shionogi Inc. from April 2015 to May 2020, and various regulatory roles at Forest Laboratories (now Allergan) between April 2011 and April 2015. Ann began the career journey as a Global Regulatory Affairs Fellow at Schering-Plough Research Institute from July 2009 to April 2011. Ann holds a PharmD/MS degree in Pharmacy from the University of Oklahoma, completed in 2009.